Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.
By M. Shichiri, H. Kishikawa, Yasuo Ohkubo, N. Wake. Diabetes Care, 2000
809 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/35847e6377cd8673f5c9b4c23065c846000d71d9
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Antonio Ceriello
- E. Motz
- L. Piconi
- Wendy L. Bennett
- E. Selvin
- N. Maruthur
- Sonal Singh
- J. Segal
Citations in the corpus
- Postprandial hyperglycemia and diabetes complications: is it time to treat? (2005, background): “Evidence accumulates suggesting that postprandial excursions of blood glucose may be involved in the development of diabetes complications, particularly (but not only) cardiovascular complications (89,90).”
- Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. (2003, background): “It is now recognized that both hyperglycemia at 2 h during an oral glucose challenge and glucose fluctuations per se are strong predictors of both cardiovascular disease (29) and microangiopathic complications (30), and it has been suggested that these “hyperglycemic spikes” may play a direct and si”
- Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus (2004, background): “However, this null result is not surprising given that this analysis combined trials that showed nonsignificant but protective effects of glycemic control (5, 11, 56, 57) with a trial (the Veterans Affairs Diabetes Feasibility Trial) that showed an increased risk for cardiovascular events in the int”
- Comparative Effectiveness and Safety of Medications for Type 2 Diabetes: An Update Including New Drugs and 2-Drug Combinations (2011, background): “To make well-informed choices among the options for achieving glucose control, clinicians and patients need comprehensive information about the effectiveness and the safety of therapies, with attention to patient-relevant outcomes (4, 9, 10).”